医薬品リファレンス
Milrinone
Milrinone is a medicine in the class cardiovascular. It is used for congestive heart failure.
- 薬効分類: Cardiovascular
- 効能・効果: congestive heart failure
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
要点
- 薬効分類
- Cardiovascular
- 一般的な剤形
- 注射剤
- 一般的な規格
- 0.2 mg/ml, 1 mg/ml, 10 mg/10 ml
- 既知の相互作用
- 8 (重大: 6 · 軽度: 2)
- 商品名
- 5
- 国・市場
- 4
何に使われるか
作用のしくみ
Phosphodiesterase inhibitor; positive inotrope with little chronotropic effect; direct vasodilator (decreases both preload and afterload)
成人の通常用量(添付文書の要約)
Congestive Heart Failure: 50 mcg/kg loading dose by IV push over 10 minutes, then 0.375-0.75 mcg/kg/min IV, Maintenance: 1.13 mg/kg/day
妊娠と授乳
- 妊娠
- Unknown Limited human data; no birth defects in rats or rabbits. Used short-term IV for severe heart failure when the mother's condition requires it.
- 授乳
- Unknown Not known if it passes into milk; no LactMed record. US label: use with caution. e-lactancia: likely to pass into milk and newborns clear it slowly; prefer an alternative, or pump and discard and wait 8 to 10 hours after a dose before nursing.
報告されている副作用
- Headache
- Hypotension
- Ventricular arrhythmias
- Supraventricular arrhythmia
- Angina/chest pain
禁忌
- Hypersensitivity to milrinone and inamrinone
注意が必要な方
- Discontinue therapy if symptoms of hepatotoxicity (eg., increased LFTs) occur; monitor liver function
- Ensure that ventricular rate is controlled in atrial fibrillation/flutter before initiating therapy; may increase ventricular response rate
- Severe aortic or pulmonic obstruction, acute phase after myocardial infarction (MI)
妊娠中または授乳中であること、腎臓や肝臓の病気、アレルギー、ほかに使用しているすべての薬やサプリメントについて、薬剤師または医師にお伝えください。
主な相互作用 (8)
- Anagrelide + Milrinone Major
- Cilostazol + Milrinone Major
- Enoximone + Milrinone Major
- Inamrinone + Milrinone Major
- Milrinone + Olprinone Major
- Milrinone + Riociguat Major
- Milrinone + Ozanimod Minor
- Milrinone + Ponesimod Minor
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、Milrinoneの完全なモノグラフ(用量、妊娠・授乳、副作用、警告、すべての相互作用)を表示できます。
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Paediatric dosing
- Pharmacokinetics
- Patient counselling points
- Food interactions
- IV preparation and dilution
WebでPro+を14日間無料でお試し。カード登録不要。
同じ分類のほかの薬剤
よくある質問
What is Milrinone used for?
Milrinone is a medicine in the class cardiovascular. It is used for Congestive heart failure.
What side effects have been reported with Milrinone?
Headache, Hypotension, Ventricular arrhythmias, Supraventricular arrhythmia, Angina/chest pain.
Can Milrinone be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Limited human data; no birth defects in rats or rabbits. Used short-term IV for severe heart failure when the mother's condition requires it. Breastfeeding: Unknown. Not known if it passes into milk; no LactMed record. US label: use with caution. e-lactancia: likely to pass into milk and newborns clear it slowly; prefer an alternative, or pump and discard and wait 8 to 10 hours after a dose before nursing.
What does Milrinone interact with?
MediHelp lists 8 known interactions for Milrinone. Major: 6 · Minor: 2. The most serious include Anagrelide, Cilostazol, Enoximone.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。